Literature DB >> 18855977

Depletion of CD4(+)CD25(+) regulatory T cells can promote local immunity to suppress tumor growth in benzo[a]pyrene-induced forestomach carcinoma.

Yi-Ling Chen1, Jung-Hua Fang, Ming-Derg Lai, Yan-Shen Shan.   

Abstract

AIM: To elucidate the distribution of CD4(+)CD25(+) regulatory T cells (Tregs) in different lymphoid tissues and its local enhancement on tumor growth before and after depletion of CD4(+)CD25(+) Tregs.
METHODS: Female ICR mice were gavaged with benzo[a]pyrene (BaP) to induce forestomach carcinoma. CD4(+)CD25(+) Tregs were intraperitoneally depleted with monoclonal antibody PC61. These mice were divided into BaP-only, BaP + IgG, BaP + PC61, and control groups. The forestomach of mice was dissected for histological analysis, and tunnel test was performed for apoptosis of tumor cells. CD4(+)CD25(+) Tregs were sorted from different lymphoid tissues and expression of Foxp3, IL-10, and chemokine receptors was analyzed by flow cytometry, semi-quantitative and real-time polymerase chain reaction.
RESULTS: The mice gavaged with only BaP showed increased forestomach papilloma and carcinoma at wk 16 and 32. The proportion of CD4(+)CD25(+) Tregs was significantly higher in peri-stomach regional lymph nodes than in other lymphoid tissues. These CD4(+)CD25(+) Tregs in regional lymph nodes expressed higher levels of Foxp3 and IL-10, enriched in the CD62L-subset, and CCR1 and CCR5 chemokine receptors. In mice gavaged with BaP + PC61, the number of tumor nodules and tumor volume decreased significantly with massive infiltrating cells and apoptosis of tumor cells. In the draining regional lymph nodes, the number of CD4(+)CD25(+) Tregs also decreased significantly.
CONCLUSION: Inducible and activated CD4(+)CD25(+) Tregs in the draining regional lymph nodes suppress host local immunity during tumor growth. Depletion of CD4(+)CD25(+) Tregs can promote host local immunity to suppress tumor growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855977      PMCID: PMC2751888          DOI: 10.3748/wjg.14.5797

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Inhibitory effects of curcumin-free aqueous turmeric extract on benzo[a]pyrene-induced forestomach papillomas in mice.

Authors:  S S Deshpande; A D Ingle; G B Maru
Journal:  Cancer Lett       Date:  1997-09-16       Impact factor: 8.679

2.  Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

Authors:  S Onizuka; I Tawara; J Shimizu; S Sakaguchi; T Fujita; E Nakayama
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

3.  Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.

Authors:  Hiromichi Kawaida; Koji Kono; Akihiro Takahashi; Hidemitsu Sugai; Kosaku Mimura; Naoto Miyagawa; Hideo Omata; Akishi Ooi; Hideki Fujii
Journal:  J Surg Res       Date:  2005-03       Impact factor: 2.192

4.  Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy.

Authors:  Michael Gough; Marka Crittenden; Uma Thanarajasingam; Luis Sanchez-Perez; Jill Thompson; Dragan Jevremovic; Richard Vile
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

5.  Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

Authors:  Lars A Ormandy; Tina Hillemann; Heiner Wedemeyer; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

6.  Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis.

Authors:  Minoru Matsuura; Kazuichi Okazaki; Akiyoshi Nishio; Hiroshi Nakase; Hiroyuki Tamaki; Kazushige Uchida; Toshiki Nishi; Masanori Asada; Kimio Kawasaki; Toshiro Fukui; Hazuki Yoshizawa; Shinya Ohashi; Satoko Inoue; Chiharu Kawanami; Hiroshi Hiai; Yasuhiko Tabata; Tsutomu Chiba
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

Review 7.  Polycyclic aromatic hydrocarbons in the diet.

Authors:  D H Phillips
Journal:  Mutat Res       Date:  1999-07-15       Impact factor: 2.433

8.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

9.  Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu.

Authors:  Chi-Chen Lin; Ching-Wen Chou; Ai-Li Shiau; Cheng-Fen Tu; Tai-Ming Ko; Yi-Ling Chen; Bei-Chang Yang; Mi-Hua Tao; Ming-Derg Lai
Journal:  Mol Ther       Date:  2004-08       Impact factor: 11.454

10.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

View more
  8 in total

1.  Association between gastric cancer and -1993 polymorphism of TBX21 gene.

Authors:  Le-Hui Zhang; Qin Li; Peng Li; Sheng-Tao Zhu; Jing Wang; Hong-Li Yang; Chang-Qing Xu; Xiu-Hua Guo
Journal:  World J Gastroenterol       Date:  2012-03-14       Impact factor: 5.742

Review 2.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

3.  CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.

Authors:  Elda Righi; Satoshi Kashiwagi; Jianping Yuan; Michael Santosuosso; Pierre Leblanc; Rachel Ingraham; Benjamin Forbes; Beth Edelblute; Brian Collette; Deyin Xing; Magdalena Kowalski; Maria Cristina Mingari; Fabrizio Vianello; Michael Birrer; Sandra Orsulic; Glenn Dranoff; Mark C Poznansky
Journal:  Cancer Res       Date:  2011-07-08       Impact factor: 12.701

Review 4.  Challenges and future perspectives of T cell immunotherapy in cancer.

Authors:  Maria Teresa P de Aquino; Anshu Malhotra; Manoj K Mishra; Anil Shanker
Journal:  Immunol Lett       Date:  2015-06-19       Impact factor: 3.685

5.  The role of regulatory T cells in cancer.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

6.  An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.

Authors:  Khairunadwa Jemon; Vivienne Young; Michelle Wilson; Sara McKee; Vernon Ward; Margaret Baird; Sarah Young; Merilyn Hibma
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

7.  Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.

Authors:  Yan-Shen Shan; Hui-Ping Hsu; Ming-Derg Lai; Meng-Chi Yen; Wei-Ching Chen; Jung-Hua Fang; Tzu-Yang Weng; Yi-Ling Chen
Journal:  Sci Rep       Date:  2015-04-30       Impact factor: 4.379

8.  Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer.

Authors:  Xiao-Mei Huang; Xiao-Sun Liu; Xian-Ke Lin; Hang Yu; Jian-Yi Sun; Xiao-Kun Liu; Chao Chen; Hai-Long Jin; Ge-Er Zhang; Xiao-Xiao Shi; Qing Zhang; Ji-Ren Yu
Journal:  Cancer Sci       Date:  2014-01-04       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.